'en:vncop-b protocol'
(id=7142618 ; fe=en:vncop-b protocol ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=416 creation date=2017-06-25 touchdate=2025-05-10 11:36:20.000) ≈ 11 relations sortantes
- en:vncop-b protocol --
r_associated #0: 38 / 1 ->
en:cisplatin/cyclophosphamide/etoposide
n1=en:vncop-b protocol | n2=en:cisplatin/cyclophosphamide/etoposide | rel=r_associated | relid=0 | w=38
- en:vncop-b protocol --
r_associated #0: 35 / 0.921 ->
en:vincristine
n1=en:vncop-b protocol | n2=en:vincristine | rel=r_associated | relid=0 | w=35
- en:vncop-b protocol --
r_associated #0: 32 / 0.842 ->
en:nsc299195
n1=en:vncop-b protocol | n2=en:nsc299195 | rel=r_associated | relid=0 | w=32
- en:vncop-b protocol --
r_associated #0: 31 / 0.816 ->
en:mitoxantrone
n1=en:vncop-b protocol | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=31
- en:vncop-b protocol --
r_associated #0: 30 / 0.789 ->
en:cyclophosphamide
n1=en:vncop-b protocol | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=30
- en:vncop-b protocol --
r_associated #0: 30 / 0.789 ->
en:etoposide
n1=en:vncop-b protocol | n2=en:etoposide | rel=r_associated | relid=0 | w=30
- en:vncop-b protocol --
r_associated #0: 28 / 0.737 ->
en:antineoplastic combined chemotherapy protocols
n1=en:vncop-b protocol | n2=en:antineoplastic combined chemotherapy protocols | rel=r_associated | relid=0 | w=28
- en:vncop-b protocol --
r_associated #0: 27 / 0.711 ->
en:prednisone
n1=en:vncop-b protocol | n2=en:prednisone | rel=r_associated | relid=0 | w=27
- en:vncop-b protocol --
r_associated #0: 26 / 0.684 ->
en:bleomycin
n1=en:vncop-b protocol | n2=en:bleomycin | rel=r_associated | relid=0 | w=26
- en:vncop-b protocol --
r_associated #0: 20 / 0.526 ->
cyclophosphamide
n1=en:vncop-b protocol | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
- en:vncop-b protocol --
r_associated #0: 3 / 0.079 ->
en:therapeutic or preventive procedure
n1=en:vncop-b protocol | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=3
| ≈ 21 relations entrantes
- cyclophosphamide ---
r_associated #0: 74 -->
en:vncop-b protocol
n1=cyclophosphamide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=74
- en:cyclophosphamide ---
r_associated #0: 71 -->
en:vncop-b protocol
n1=en:cyclophosphamide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=71
- en:nsc299195 ---
r_associated #0: 28 -->
en:vncop-b protocol
n1=en:nsc299195 | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=28
- en:antineoplastic combined chemotherapy protocols ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:antineoplastic combined chemotherapy protocols | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:bleomycin ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:bleomycin | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:cisplatin/cyclophosphamide/etoposide ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:cisplatin/cyclophosphamide/etoposide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:etoposide ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:etoposide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:mitoxantrone ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:mitoxantrone | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:prednisone ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:prednisone | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- en:vincristine ---
r_associated #0: 20 -->
en:vncop-b protocol
n1=en:vincristine | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=20
- cyclope (oeil) ---
r_associated #0: 15 -->
en:vncop-b protocol
n1=cyclope (oeil) | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=15
- Cyclophosphamide ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=Cyclophosphamide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- bléomycine ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=bléomycine | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- en:cyclops eye ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=en:cyclops eye | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- mitoxantrone ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=mitoxantrone | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- prednisone ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=prednisone | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- vincristine ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=vincristine | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- étoposide ---
r_associated #0: 10 -->
en:vncop-b protocol
n1=étoposide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=10
- cyclopeptide ---
r_associated #0: 5 -->
en:vncop-b protocol
n1=cyclopeptide | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=5
- cyclophiline ---
r_associated #0: 5 -->
en:vncop-b protocol
n1=cyclophiline | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=5
- cyclophorie ---
r_associated #0: 5 -->
en:vncop-b protocol
n1=cyclophorie | n2=en:vncop-b protocol | rel=r_associated | relid=0 | w=5
|